Specialty Pharmacy

WASHINGTON — The Center for Pharmacy Practice Accreditation has awarded specialty pharmacy US Bioservices, a part of AmerisourceBergen, its specialty pharmacy practice accreditation, the organization announced Friday.

DEERFIELD, Ill. — Walgreens and Greater Than AIDS, a leading national public information response to the domestic HIV/AIDS epidemic, are teaming up for the seventh straight year with health departments and local AIDS service organizations to offer free HIV testing and counseling about prevention strategies, including Pre-Exposure Prophylaxis, as part of a National HIV Testing Day effort.

WASHINGTON — In a decision that will have a big impact on the burgeoning biosimilars market, the Supreme Court on Monday overturned an appeals court decision which said Sandoz had to wait 180 days under federal law after receiving Food and Drug Administration approval to launch its biosimilar of Amgen’s Neupogen (filgrastim), Zarxio (filgrastim-sndz). The court did not rule out the possibility of state law allowing such an injunction, sending that question to a lower court.

WASHINGTON — Generics continue to play a key role in the healthcare system, according to the the Association for Accessible Medicines’ recently released ninth annual Generic Access and Savings in the U.S. report, compiled by the QuintilesIMS Institute for the AAM (formerly the Generic Pharmaceutical Association). The report highlights that generic drugs saved the healthcare system $253 billion in 201, bringing 10-year savings to $1.67 trillion.

SILVER SPRING, Md. — The Food and Drug Administration on Friday announced its approval of Teva’s abbreviated new drug application the first generic of Gilead’s Truvada (emtricitabine and tenofovir disoproxil).

The drug is indicated both as a treatment for HIV-1 in combination with other antiretroviral drugs and for pre-exposure prophylaxis to prevent sexually acquired HIV infection in combination with safer sex practices. 

CINCINNATI — Diplomat subsidiary Diplomat Specialty Infusion Group was among the Cincinnati Enquirer's Top Workplaces 2017. The results come from an employee survey that measured such aspects of workplace culture as alignment, execution and connection.

DANBURRY, Conn. and RESEARCH TRIANGLE PARK, N.C. — The latest report from the QunitilesIMS Institute is highlighting strides made in oncology therapies and the robust pipeline of forthcoming treatments.

The report, Global Oncology Trends 2017: Advances, Complexity and Cost, notes that 68 novel therapies have been approved globally across 22 cancer indications since 2011, providing more access and better outcomes for patients, particularly those with metastatic cancers.